A Qualitative Study of the German Experience
Lawrenceville, NJ, USA—September 18, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a study providing detailed information on factors determining the adoption of new technologies from clinicians’ points of view. The report, Physicians’ Decision Making on Adoption of New Technologies and Role of Coverage With Evidence Development: A Qualitative Study, was published in the September 2018 issue of Value in Health.
Researchers conducted 23 in-depth one-on-one interviews with chief and senior physicians of vascular surgery and cardiology in inpatient care in the city of Berlin and the German state of Brandenburg. The authors identified a total of 52 individual factors that physicians described as influencing their decision to adopt a new technology. The authors grouped these influencing factors into 8 thematic categories: 1) technology, 2) evidence base, 3) state of medical care, 4) manufacturer, 5) regulation, 6) hospital (including its institutional characteristics and strategy), 7) individual, and 8) patient. While these 8 categories are largely similar to the categories of influencing factors in German inpatient care recognized in previous studies, several new thematic categories were identified, including the state of medical care, manufacturer-related issues, and the robustness of the available evidence base.
Indeed, physicians considered available evidence as an important issue influencing their decision. “For many technologies, our results indicated that physicians perceived the evidence base at the time of market entry to be scarce,” said lead author Susanne Felgner, MSc, Department of Health Care Management, Technische Universität Berlin, Berlin, Germany. “Respondents criticized the overall lack of studies, the small number of patients in approval studies, and the supposed influence of manufacturers on studies. Physicians also complained that some new technologies were financed too early through the German instrument of innovation payments. In the end, the trade-off between time of adoption and evidence base is highly relevant in physicians’ technology adoption decisions.”
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg
ABOUT VALUE IN HEALTH
Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2017 impact factor score is 5.494. Value in Health is ranked 3rd among 94 journals in healthcare sciences and services, 3rd among 79 journals in health policy and services, and 6th among 353 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world.
Web: www.ispor.org/valueinhealth_index.asp | Twitter: www.twitter.com/ISPORJournals (@ISPORjournals)